NCT02690961View on ClinicalTrials.gov

Study of Multiple-dose Kukoamine B Mesilate in Healthy Volunteers

PHASE1CompletedINTERVENTIONAL
Enrollment

24

Participants

Timeline

Start Date

March 31, 2016

Primary Completion Date

June 14, 2016

Study Completion Date

June 14, 2016

Conditions
Healthy
Interventions
DRUG

Kukoamine B Mesilate

Kukoamine B Mesilate or placebo single-dose and intravenous(IV) drip for 1 hour in healthy volunteers.

DRUG

placebo multiple doses

Trial Locations (1)

Unknown

Peking Union Medical College Hospital, Beijing

All Listed Sponsors
collaborator

Southwest Hospital, China

OTHER

lead

Tianjin Chasesun Pharmaceutical Co., LTD

INDUSTRY

NCT02690961 - Study of Multiple-dose Kukoamine B Mesilate in Healthy Volunteers | Biotech Hunter | Biotech Hunter